Picture of flying drone

Award-winning sensor signal processing research at Strathclyde...

The Strathprints institutional repository is a digital archive of University of Strathclyde's Open Access research outputs. Strathprints provides access to thousands of Open Access research papers by University of Strathclyde researchers, including by Strathclyde researchers involved in award-winning research into technology for detecting drones. - but also other internationally significant research from within the Department of Electronic & Electrical Engineering.

Strathprints also exposes world leading research from the Faculties of Science, Engineering, Humanities & Social Sciences, and from the Strathclyde Business School.

Discover more...

A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia

Boyle, P. and Robertson, C. and Vaughan, E. Darracott and Fitzpatrick, John M. (2004) A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. British Journal of Urology International, 94 (1). pp. 83-88. ISSN 1464-4096

Full text not available in this repository. (Request a copy from the Strathclyde author)


This section opens with two meta-analyses, the first into the use of transurethral needle ablation (TUNA) for treating symptomatic BPH and the second into comparative trials between transurethral electrovaporization and TURP. The first of these meta-analyses showed that despite a variety of trial methods, not all were satisfactory. TUNA was effective in improving symptoms and flow rates. The place of this therapy in the treatment of symptomatic BPH is suggested. In the second meta-analysis, methodological shortcomings of the various trials are again discussed. The possible advantages of both of these treatments are described, but the authors suggest that there is a need for future well-designed trials with extended follow-up. This seems to be the ultimate conclusion of a significant number of the meta-analysis into technological treatments for symptomatic BPH.